NEWS 23

🔒
❌
Stats
Es gibt neue verfügbare Artikel. Klicken Sie, um die Seite zu aktualisieren.
Gestern — 13. April 2026

What Big Pharma Hopes You Never Discover: Three Forgotten Molecules That Can Hand You Back The Energy of a 30-Year-Old

13. April 2026 um 15:00

Vorschau ansehen
A smiling man hiking on a mountain trail with a backpack, surrounded by scenic valleys and sunlight.

(Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the links below which benefits Gateway Pundit. We appreciate your support!)

A smiling man hiking on a mountain trail with a backpack, surrounded by scenic valleys and sunlight.

If you could flip a switch and feel like a 30-year-old again, you would’ve done it yesterday.

You’ve choked down caffeine like it’s rocket fuel. You’ve done the 10-step morning routines, cutting carbs, the 5 a.m. miracles, the keto crusades, the ice-bath insanity. Still dragging by lunch.

Face it: if sheer grit and Google searches were enough, you’d be a walking dynamo right now. You’re not. The reason? Your mitochondria are on life support.

Modern life is a cellular mugging—stress, bad food, blue light, all stealing what your mitochondria are screaming for. Ignore the screams long enough and you become a walking zombie.

The truth is brutal: our mitochondria are starving.

Here comes the cavalry nobody else is talking about: Methylene Blue, NAD, and PQQ. Three heavy hitters, one knockout punch – combined into one tablet: Recharge. 

The heavy hitters of Recharge:

  • Methylene Blue—the same stuff Navy SEAL docs and Nobel winners have geeked out over for a century—flips your mitochondria into overdrive and floods your brain with oxygen. Without it, you’re thinking with a wet blanket over your skull.

  • NAD? Your levels tanked the day you blew out 30 candles. That’s why food turns to sludge instead of jet fuel. Top it off or stay stuck.

  • PQQ? This bad boy grows brand-new mitochondria like a mad scientist on payday. You can’t eat enough blueberries on God’s green earth to move the needle.

Recharge is the world’s first tablet to combine pharmaceutical-grade Methylene Blue, NAD, and PQQ. Nothing else even comes close.

Two capsules with your morning coffee. That’s the entire “protocol.” Willpower-proof.

Day three, people notice. Day seven, you scare people with how much you’re getting done.

One guy wrote in: “I feel 10 years younger & looking to do more traveling like I used to 10 years ago!”

Another wrote, “I have chronic fatigue from trauma and toxin exposure, and this supplement almost immediately relieved it.” Miraculous.

You’ve already proven every other “solution” is a scam on your wallet and a joke on your biology. How much more proof do you need?

Your move. Keep limping along or click over to The Wellness Company and grab the one thing your cells have been begging for since the day you started slowing down. 

The energy isn’t coming back on its own. But it’s one click away. Tick-tock.

The post What Big Pharma Hopes You Never Discover: Three Forgotten Molecules That Can Hand You Back The Energy of a 30-Year-Old appeared first on The Gateway Pundit.

(Auszug von RSS-Feed)

Economist Who Predicted 2008 and 2020 Crashes: “Prepare for AI Meltdown”

12. April 2026 um 21:00

Vorschau ansehen
A computer screen displays a digital brain and robotic hands analyzing stock market trends, with a professional speaker in an inset circle.

Note: The information provided here or in any related communications is for informational purposes only and should not be considered as financial advice. We do not provide personalized investment, financial, or legal advice. Gateway Pundit benefits from purchases made through our sponsors.

A computer screen displays a digital brain and robotic hands analyzing stock market trends, with a professional speaker in an inset circle.

Whenever this man issues a stock market warning…

You should stop and listen because…

He’s the famous economist and best-selling author who predicted the two biggest stock market crashes of the last two decades.

He predicted the 2008 meltdown…

Just three weeks before Lehman Brothers imploded and the stock market collapsed…

And he predicted the COVID meltdown…

Again just three weeks before the stock market suffered the fastest drop in history.

He’s now predicting we’re about to see an AI meltdown of historic proportions…

Similar to what happened in 2000 during the dotcom bust…

When the stock market crashed almost 80%…

Ruining the retirement of millions of Americans.

In short, he believes the most important AI company in the world is about to go bust…

In a meltdown that will be 10 times bigger than Lehman Brothers…

….sending a ripple effect through the market that could crater the entire AI industry.

And he’s warning everyone to take these five simple steps to prepare.

The post Economist Who Predicted 2008 and 2020 Crashes: “Prepare for AI Meltdown” appeared first on The Gateway Pundit.

(Auszug von RSS-Feed)
Ältere Beiträge

How to Legally Stiff-Arm Interest Charges for Almost Two Years and Pocket Thousands Like a Boss

12. April 2026 um 15:00

Vorschau ansehen
A person using a tablet to navigate a financial app displaying a 0% intro APR offer and a button to transfer balance, with credit cards and a calculator nearby.

(Note: Thank you for supporting businesses like those presenting a sponsored message below and ordering through the links below, which benefits Gateway Pundit. We appreciate your support!)

A person using a tablet to navigate a financial app displaying a 0% intro APR offer and a button to transfer balance, with credit cards and a calculator nearby.

If you’re sick of watching interest charges devour your paycheck like a starving pit bull on a steak, pay attention, because we’re going to talk about the closest thing to free money the banks have ever been forced to cough up.

Right now, a handful of cards are handing out 0% interest for up to 21 months on both new purchases and balance transfers. No tricks, no “gotcha” in the fine print that only a Harvard lawyer can decode — just pure, uncut breathing room.

These aren’t fly-by-night outfits; they’re the big, boring banks your grandma trusted, the ones with vaults thicker than a politician’s skull and fraud protection that actually works when some teenager in Romania tries to buy a jet ski with your number.

You move your existing debt over in the first 60–90 days and suddenly that $8,000 at 24% is sitting pretty at zero. Do the math — that’s two grand you don’t flush down the toilet.

Picture this: next Christmas rolls around and you’re not sweating bullets. You buy the gifts, book the trip, fix the furnace, whatever, and nothing bleeds interest for almost two years while you pay it down on your terms.

Good credit? You’re in like Flynn. Fair credit? A couple of these will still roll out the red carpet. The application takes five minutes, and half the time you get an answer before your coffee gets cold.

Most have no annual fee — none, zero, zip — so the card can sit in your wallet earning dust or earning rewards, your call.

Some of these beasts even waive late fees completely. Miss a payment because life exploded? No $40 spanking and no credit-score gut punch. That alone is worth its weight in gold-plated titanium.

When the intro period ends, the ongoing rate is sane — not the 79% loan-shark nonsense you see on late-night TV. Plus you’re stacking cash back, travel miles, or points on groceries, gas, and everything else you were going to buy anyway.

You’re looking at 21-month runways. That’s long enough to kill off revolving debt, remodel the kitchen, or fund the side hustle without paying a dime in interest if you play it smart.

Fraud? They’ve got real-time alerts, one-tap card freeze, and zero liability. Your money is safer than a squirrel’s nut stash under six feet of snow.

Balance-transfer fees are posted in plain English up front — usually 3% or less — so there’s no “surprise” that makes you want to throw your laptop out the window.

Bottom line: these deals are the financial equivalent of finding a loaded wallet on the sidewalk with a note that says “keep it.”

You keep scrolling past these offers and nothing changes. You click, fill out the short form, and suddenly you’re the one in control instead of the credit-card companies. 

A tip: Don’t just apply for one card – apply for three at one time and see which get approved.

Stop wrestling with interest charges that grow faster than a teenager’s gaming habit. Grab one of these 0% offers before the bean counters wake up and kill them.

One click here, five minutes, and you just handed yourself a raise you’ll feel every single month. 

Your move. The clock’s ticking, and these intro periods won’t last forever.

The post How to Legally Stiff-Arm Interest Charges for Almost Two Years and Pocket Thousands Like a Boss appeared first on The Gateway Pundit.

(Auszug von RSS-Feed)

Tiny $2 Mining Stock 2X Bigger Than Barrick? Is This The #1 Gold Play For 2026?

11. April 2026 um 15:00

Vorschau ansehen
Man in a black blazer and blue shirt speaking confidently in an office setting, with decorative shelves in the background.

Note: The information provided here or in any related communications is for informational purposes only and should not be considered as financial advice. We do not provide personalized investment, financial, or legal advice. Gateway Pundit benefits from purchases made through our sponsors.

Man in a black blazer and blue shirt speaking confidently in an office setting, with decorative shelves in the background.

Barrick is one of the largest mining companies in the world, with a value of nearly $100 billion.

Since its IPO several decades ago, Barrick shares have risen by as much as 54X – enough to turn a $2,500 investment into $135,000.

Yet as great as that is, Barrick’s results might be dwarfed over time by this much smaller $2 gold stock.

While Barrick has reserves of 86 million ounces of gold, this tiny gold play is sitting on the equivalent of 161 million ounces.

That makes it almost 2X bigger than Barrick!

But despite that, this virtually unknown stock is just 1/100th the size of Barrick.

After April 15, however, everything could change practically overnight for this tiny $2 gold play.

And investors could see a tiny stake grow by 10X or more over the next few months alone.

Click here to learn the urgent details.

The post Tiny $2 Mining Stock 2X Bigger Than Barrick? Is This The #1 Gold Play For 2026? appeared first on The Gateway Pundit.

(Auszug von RSS-Feed)

The SpaceX IPO Isn’t the Play – The Real Money Moves Before It

10. April 2026 um 15:00

Vorschau ansehen
Business professionals in a conference room reviewing a capital allocation strategy presentation with a city skyline in the background.

Note: The information provided here or in any related communications is for informational purposes only and should not be considered as financial advice. We do not provide personalized investment, financial, or legal advice. Gateway Pundit benefits from purchases made through our sponsors.

Business professionals in a conference room reviewing a capital allocation strategy presentation with a city skyline in the background.

by Jeff Brown

Everyone’s waiting for SpaceX to go public.

That’s the mistake.

IPOs are liquidity events.
They’re not ground-floor opportunities.

By the time the bell rings:
• Early capital is already multiplied
• Institutions are already positioned
• Valuation has already expanded

This isn’t new.

Amazon. Google. Tesla.
Opening day buyers didn’t build generational wealth.

Early positioning did.

What if you could compress a lifetime of wealth-building…

Ten… twenty… even thirty years…

Into a single 24-hour window?

It sounds absurd.

But Elon Musk is about to make it a reality with something I’m calling…

“Day-One Retirement Plan.” Click here to see the details.

The post The SpaceX IPO Isn’t the Play – The Real Money Moves Before It appeared first on The Gateway Pundit.

(Auszug von RSS-Feed)

Groundbreaking New Study Regarding Ivermectin and Cancer

09. April 2026 um 15:00

Vorschau ansehen
Infographic displaying self-reported cancer outcomes at six-month follow-up, highlighting percentages of patients with no evidence of disease, regression, stable disease, and progression.

(Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the links below which benefits Gateway Pundit. We appreciate your support!)Infographic displaying self-reported cancer outcomes at six-month follow-up, highlighting percentages of patients with no evidence of disease, regression, stable disease, and progression.

Before the COVID-19 pandemic, the vast majority of Americans – regardless of their ideological leanings – simply trusted the medical establishment. That trust was devastated by the experience of the pandemic. According to polling, in April 2020 – at the outbreak of the pandemic – 71.5% of respondents reported having “a lot of trust” in physicians and hospitals. By January 2024, that number had plummeted to 40.1%.

Unfortunately, trust in our healthcare system and its institutions has been undermined by a belief that decisions are being made – not based on what is in the best interest of Americans healthcare – but what is in the best interest of corporate bottom lines.

To restore faith in our system, we need research and treatment that is focused on the patient’s health – not just profit. That’s where The Wellness Company comes in.

Dr. Peter McCullough, and a number of his colleagues at The Wellness Company, have recently authored a first of its kind study of the application of Ivermectin+Mebendazole in the treatment of cancer.

84% of Cancer Patients Reported a Clinical Benefit

In this human observational analysis, off-label use of Ivermectin+Mebendazole showed a remarkable 84% Clinical Benefit Ratio in the treatment of cancer. These results indicate that the inexpensive and safe off-label applications of these medications could be an important breakthrough in the treatment of cancer.

The report analyzed 197 cancer patients who were prescribed ivermectin and mebendazole off label. Participants received compounded oral capsules containing 25 mg of ivermectin and 250 mg of mebendazole. After 6-months, participants reported an 84% Clinical Benefit Ratio. With 48% of participants reporting regression or no evidence of cancer, while 36% reported disease stability. Only 15.6% of participants reported disease progression.

Cancer remains one of the leading causes of death globally, with conventional treatments such as chemotherapy, radiation therapy, and targeted agents frequently limited by significant toxicity, high cost, development of resistance, and variable long-term efficacy.

The experts at The Wellness Company undertook this study because ivermectin and mebendazole have demonstrated highly promising anti-cancer activity in preclinical models. But despite compelling preclinical data and documented safe use in cancer patients, robust clinical evidence evaluating the ivermectin–mebendazole combination in oncology remains limited.

According to Dr. McCullough, “This study reveals an exciting new potential that should expand the consideration of ivermectin and mebendazole for inclusion in the treatment of multiple cancer types. We urgently need a full-fledged scientific investigation into this class of medications and their impact on cancer treatment.”

How You Can Get Ivermectin + Mebendazole

The Wellness Company is the only company in the world to prescribe compounded Ivermectin + Mebendazole, in a high-dose 90-day supply:

Ivermectin – Backed by science and honored with a Nobel Prize, Ivermectin delivers precise treatment against parasitic infections, ensuring effective care and well-being for your family with trusted precision.

Mebendazole – Trusted by healthcare professionals, Mebendazole targets and eliminates intestinal parasites with precision, ensuring your family’s health and well-being with proven efficacy and safety.

Head over to The Wellness Company today to order a 90-day supply of the ultimate parasite cleanse – Ivermectin + Mebendazole. Simply fill out the 2-minute intake questionnaire after checkout to complete your prescription request.

What people are saying about The Wellness Company’s Ivermectin + Mebendazole:

I am grateful to have a medicine as potentially beneficial as ivermectin and mebendazole, but the most important thing for me is the faith I have in Dr. McCullough and The Wellness Company for making a safe product, in our country. I am grateful for them protecting us through the use of proven products and the peace in knowing that I’m taking something that is precisely what it states on the labels. – Jennifer W.

My daughter was diagnosed with uterine cancer and lung nodules that turned out to be cancerous. She started taking ivermectin/mebendazole 2 weeks ago. She had a PET scan last month and her lungs were littered with dime and pea sized nodules from the top to the bottom of her lungs. She had a biopsy on the 14th of April and the Physcian had to SEARCH for a nodule big enough to get a sample from, and the ONE that he found was at the bottom of her left lung that he said was only a few centimeters wide…. Thank All of you Doctors on this site for giving us HOPE and HEALING!!! – Helen

Order Ivermectin and Mebendazole from The Wellness Company today!

Note: The information provided here is intended for informational purposes only and should not be considered medical advice or used as a substitute for professional healthcare guidance. It is your responsibility to comply with all applicable laws, regulations, and guidelines regarding the purchase, possession, and use of prescription medications.

The post Groundbreaking New Study Regarding Ivermectin and Cancer appeared first on The Gateway Pundit.

(Auszug von RSS-Feed)
❌